Hanmi's New Story
힘차게 도약하는 한미
함께하는 미래
한미약품의 새로운 이야기가 펼쳐집니다.
Meet Us at American Association for the Study of Liver Diseases (AASLD) 2024 The Liver Meeting.
Glucagon engagement is essential for the direct anti-inflammation and anti-fibrosis effect of efocipegtrutide in TAA-induced mouse model of liver injury and fibrosis
- Poster Number
- 1084
- Session
- Poster Session I, Nov 15 2024 at 1:00 PM ~ 2:00 PM (GMT-7)
- Presenter
-
Yohan Kim
/ Hanmi Pharmaceuticalyohan.kim@hanmi.co.kr
Meet Us at the 62nd Annual European Society for Paediatric Endocrinology (ESPE) Meeting 2024.
Safety and efficacy of efpegerglucagon in patients with congenital hyperinsulinism: interim results from a phase 2 study
- Poster Number
- P1-309
- Session
- P1 printed Poster, Nov 16 at 10:00 AM ~ 6:00 PM GMT, Exhibition Hall
- Presenter
-
Antonia Dastamani /
Great Ormond Street Hospital, UKAntonia.Dastamani@gosh.nhs.uk
